Patents by Inventor John Ross, Jr.

John Ross, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
    Patent number: 11944099
    Abstract: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: April 2, 2024
    Assignee: CORTEVA AGRISCIENCE LLC
    Inventors: Ronald J. Heemstra, Ronald Ross, Jr., Timothy P. Martin, Nicolaas Vermeulen, John F. Daeuble, Sr., Joseph D. Eckelbarger, Alex Nolan, Kaitlyn Gray, David A. Demeter, Ricky Hunter, Tony K. Trullinger
  • Methods for cardiac gene transfer
    Patent number: 7399750
    Abstract: Methods for the delivery of genes to improve cardiac function including the use of viral vectors, isolation of the heart from systemic circulation, and induction of hypothermia/cardiac arrest are described. The method results in high-level, long-term expression of reporter genes and enhanced cardiac function in hamster models of heart disease.
    Type: Grant
    Filed: September 11, 2001
    Date of Patent: July 15, 2008
    Assignee: The Regents of the University of California
    Inventors: Kenneth R. Chien, Masahiko Hoshijma, John Ross, Jr., Yasuhiro Ikeda
  • Treatment of heart failure with growth hormone
    Patent number: 6770624
    Abstract: Heart failure following myocardial infarction is treated by administration of an angiotensin II inhibitor for 8-12 weeks, followed by administration of a growth hormone for 1-3 weeks.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: August 3, 2004
    Assignee: The Regents of the University of California
    Inventors: John Ross, Jr., Kenneth R. Chien
  • Treatment of heart failure with growth hormone
    Patent number: 6306826
    Abstract: Heart failure following myocardial infarction is treated by administration of an angiotensin II inhibitor for 8-12 weeks, followed by administration of a growth hormone for 1-3 weeks.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: October 23, 2001
    Assignee: The Regents of the University of California
    Inventors: John Ross, Jr., Kenneth R. Chien